The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 9723K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ehl, S.
Right arrow Articles by Pircher, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ehl, S.
Right arrow Articles by Pircher, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1998/3/763/ $5.00
The Journal of Experimental Medicine, Volume 187, Number 5, March 2, 1998 763-774


Articles

Viral and Bacterial Infections Interfere with Peripheral Tolerance Induction and Activate CD8+ T Cells to Cause Immunopathology

Stephan Ehl, Joachim Hombach, Peter Aichele, Thomas Rülicke, Bernhard Odermatt, Hans Hengartner, Rolf Zinkernagel, and Hanspeter Pircher

From the Institute of Experimental Immunology, CH-8091 Zürich, Switzerland

We studied the impact of various infectious and proinflammatory agents on the induction of peripheral T cell tolerance. Adoptive transfer of CD8+ T cells from lymphocytic choriomeningitis virus (LCMV) T cell receptor transgenic mice into LCMV antigen transgenic mice expressing the LCMV glycoprotein epitope (gp) 33–41 under control of a major histocompatibility complex class I promoter led to efficient induction of peripheral tolerance after a period of transient activation. If, however, the recipient mice were challenged with viral or bacterial infections or proinflammatory agents (lipopolysaccharide or Poly:IC) early after cell transfer, tolerance induction was prevented and instead, CD8+ T cell activation leading to vigorous expansion and generation of cytolytic activity ensued. This became manifest in significant immunopathology mainly involving destruction of the splenic architecture and lysis of antigen-expressing lymphocyte and macrophage populations. Important parameters involved in the activation of host-reactive T cells by nonspecific infectious agents included the presence, localization, and quantity of the specific transgene-encoded self-antigen; in contrast, CD4+ T cells were not required. In mice surviving the acute phase, the transferred CD8+ T cells persisted at high levels in an anergic state; they were unable to generate cytolytic activity in vitro or to control LCMV infection in vivo. These results impinge on our understanding of the role of infectious agents in graft verus host reactions towards minor histocompatibility antigens.


We thank Karin Riem for excellent technical assistance.

This work was supported by the Swiss National Foundation grant 31-32179.91 (to H. Hengartner), grant 31-32195.91 (to R. Zinkernagel), and the Deutsche Forschungsgemeinschaft (to S. Ehl).

Address correspondence to Dr. Stephan Ehl, Institute of Experimental Immunology, Department of Pathology, University of Zürich, Schmelzbergstr. 12, CH-8091 Zürich, Switzerland. Phone: 411-255-2328; Fax: 411-255-4420; E-mail: stephehl{at}usz.unizh.ch

The present address of J. Hombach is Global Program for Vaccines and Immunization, World Health Organization, CH-1211 Geneva 27, Switzerland. The present address of H. Pircher is Institute for Medical Microbiology and Hygiene, Department of Immunology, University of Freiburg, D-79104 Freiburg, Germany.

1 Abbreviations used in this paper: aa, amino acids; CFSE, 5,6 carboxyfluorescein diacetate succinimidyl ester; FDC, follicular dendritic cell; GP, glycoprotein; GVH, graft versus host; GVHR, GVH reaction; H8 mice, LCMV gp33-transgenic mice; L, ligand; LCMV, lymphocytic choriomeningitis virus; NP, nucleoprotein; RAG, recombination activating gene; VSV, vesicular stomatitis virus.

J. Hombach and S. Ehl contributed equally to this work.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS